Literature DB >> 11157659

Antithrombotic therapy in children.

P Monagle, A D Michelson, E Bovill, M Andrew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11157659     DOI： 10.1378/chest.119.1_suppl.344s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  30 in total

1.  Paediatric acute basilar thrombosis successfully treated with intravenous alteplase.

Authors:  Paulo Rego Sousa; Rui Vasconcellos
Journal:  BMJ Case Rep       Date:  2012-05-08

2.  Diabetic ketoacidosis and pediatric stroke.

Authors:  Josephine Ho; Danièle Pacaud; Michael D Hill; Catherine Ross; Lorie Hamiwka; Jean K Mah
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

3.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Hemiconvulsion, hemiplegia, epilepsy syndrome and inherited protein S deficiency.

Authors:  R K Mondal; D Chakravorty; S Das
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

5.  Management of warfarin in children with heart disease.

Authors:  Sophie Jones; Fiona Newall
Journal:  Pediatr Cardiol       Date:  2011-10       Impact factor: 1.655

Review 6.  The pediatric cardiology pharmacopeia: 2013 update.

Authors:  Paul Nicholas Severin; Sawsan Awad; Beth Shields; Joan Hoffman; William Bonney; Edmundo Cortez; Rani Ganesan; Aloka Patel; Steve Barnes; Sean Barnes; Shada Al-Anani; Umang Gupta; Yolandee Bell Cheddar; Ismael E Gonzalez; Kiran Mallula; Hani Ghawi; Suhaib Kazmouz; Salwa Gendi; Ra-id Abdulla
Journal:  Pediatr Cardiol       Date:  2012-11-29       Impact factor: 1.655

7.  Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.

Authors:  Lela S Fung; Christopher Klockau
Journal:  J Pediatr Pharmacol Ther       Date:  2010-04

8.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

9.  Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?

Authors:  Wesley D Kufel; Robert W Seabury; William Darko; Luke A Probst; Christopher D Miller
Journal:  Hosp Pharm       Date:  2017-03

Review 10.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.